Takeda Pharmaceutical Co Ltd
TAK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395064
In the last 90 days, Takeda Pharmaceutical Co Ltd insiders filed 0 open-market purchases and 19 sales; 379 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; no superinvestor holds it.
Other share classesTKPHF
Q3 2023 vs. Q2 2023
How the institutions holding Takeda Pharmaceutical Co Ltd changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 312 | 7 | 313 | +8 |
| Shares | 84.0M | 239.6K | 80.4M | −3.37M (−4.0%) |
| Value | $1.32B | $3.76M | $1.24B | −$73.7M (−5.6%) |
7 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (39)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (31)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (7)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| BFT Financial Group, LLC | 129,870 | $2.04M |
| Tekla Capital Management LLC | 105,073 | $1.65M |
| Kistler-Tiffany Companies, LLC | 4,105 | $64.5K |
| Coastal Capital Group, Inc. | 206 | $3.24K |
| Piershale Financial Group, Inc. | 173 | $2.72K |
| BDO Wealth Advisors, LLC | 103 | $1.62K |
| BerganKDV Wealth Management, LLC | 50 | $786 |